StockData
Vericel Corp logo

Vericel Corp (VCEL) stock

VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/30329% above fair value
$58.65+0.77 (+1.33%)

Close on Nov 18, 2026Market cap $3.00BP/E 139.6Yield –

Vericel gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Vericel's gross profit for the twelve months ending Jun 30, 2026 was $228.38M, up 24.8% year over year. For fiscal 2025 it was $205.60M, up 19.5% from the year before. Over ten years it grew 23.6% a year on average. The highest annual figure on record is $205.60M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$205.60M+19.5%
FY2024Dec 31, 2024$172.11M+26.9%
FY2023Dec 31, 2023$135.58M+23.5%
FY2022Dec 31, 2022$109.79M+3.5%
FY2021Dec 31, 2021$106.03M+25.9%
FY2020Dec 31, 2020$84.23M+4.9%
FY2019Dec 31, 2019$80.28M+36.8%
FY2018Dec 31, 2018$58.70M+74.8%
FY2017Dec 31, 2017$33.57M+28.7%
FY2016Dec 31, 2016$26.08M+5.6%
FY2015Dec 31, 2015$24.70M+114.7%
FY2014Dec 31, 2014$11.50M+76586.7%
FY2013Dec 31, 2013$15.00K0.0%
FY2012Dec 31, 2012$15.00K-72.7%
FY2010Jun 30, 2010$55.00K-21.4%
FY2009Jun 30, 2009$70.00K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$56.40M+21.0%
Q1 FY2026Mar 31, 2026$49.27M+35.8%
Q4 FY2025Dec 31, 2025$73.13M+25.0%
Q3 FY2025Sep 30, 2025$49.59M+19.0%
Q2 FY2025Jun 30, 2025$46.61M+27.4%
Q1 FY2025Mar 31, 2025$36.27M+2.6%
Q4 FY2024Dec 31, 2024$58.50M+20.6%
Q3 FY2024Sep 30, 2024$41.65M+36.1%
Q2 FY2024Jun 30, 2024$36.60M+22.2%
Q1 FY2024Mar 31, 2024$35.35M+33.3%
Q4 FY2023Dec 31, 2023$48.51M+26.8%
Q3 FY2023Sep 30, 2023$30.61M+21.3%
Q2 FY2023Jun 30, 2023$29.94M+31.0%
Q1 FY2023Mar 31, 2023$26.52M+13.1%
Q4 FY2022Dec 31, 2022$38.25M+12.4%
Q3 FY2022Sep 30, 2022$25.23M+14.2%
Q2 FY2022Jun 30, 2022$22.85M-15.1%
Q1 FY2022Mar 31, 2022$23.45M+2.0%
Q4 FY2021Dec 31, 2021$34.03M+1.1%
Q3 FY2021Sep 30, 2021$22.10M-1.7%
Q2 FY2021Jun 30, 2021$26.91M+137.0%
Q1 FY2021Mar 31, 2021$22.99M+37.2%
Q4 FY2020Dec 31, 2020$33.65M+16.8%
Q3 FY2020Sep 30, 2020$22.47M+6.1%
Q2 FY2020Jun 30, 2020$11.35M-33.7%
Q1 FY2020Mar 31, 2020$16.76M+27.2%
Q4 FY2019Dec 31, 2019$28.81M+26.9%
Q3 FY2019Sep 30, 2019$21.18M+47.6%
Q2 FY2019Jun 30, 2019$17.13M+51.8%
Q1 FY2019Mar 31, 2019$13.17M+27.1%
Q4 FY2018Dec 31, 2018$22.71M+51.8%
Q3 FY2018Sep 30, 2018$14.35M+102.8%
Q2 FY2018Jun 30, 2018$11.28M+21.6%
Q1 FY2018Mar 31, 2018$10.36M+360.1%
Q4 FY2017Dec 31, 2017$14.96M0.0%
Q3 FY2017Sep 30, 2017$7.07M+73.7%
Q2 FY2017Jun 30, 2017$9.28M–
Q1 FY2017Mar 31, 2017$2.25M–
Q4 FY2016Dec 31, 2016$14.96M–
Q3 FY2016Sep 30, 2016$4.07M–

More Vericel figures

See a number that looks wrong?